Gulf Coast TX
AI companies run virtual drug trials, aim to improve success of human studies
By Deena Beasley Oct 7 (Reuters) -- Novartis' experimental del-desiran for a rare type of muscular dystrophy was expected to be a winner, with the Swiss company's CEO predicting an…
